Candidates include individuals with ureteral stones, strictures, tumors, or recurrent urinary tract infections that require direct intervention.

The Anti-Phospholipid Antibody Test detects antibodies against phospholipids, helping diagnose antiphospholipid syndrome (APS) and assess the risk of blood clots.

A blood sample is collected from a vein in your arm and analyzed for the presence of antiphospholipid antibodies.

No fasting or special preparation is required. You can eat and drink normally before the test.

Results are usually available within 1-2 days, depending on the laboratory’s processing time.

Discuss any abnormal results with your healthcare provider, who will guide you on further tests or treatment options based on your specific condition.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.